We would like to ensure that you are still receiving content that you find useful – please confirm that you would like to continue to receive ILO newsletters.
August 08 2018
Health Canada recently issued updated guidance on the Patented Medicines (Notice of Compliance) (PMNOC) Regulations reflecting the 21 September 2017 amendments (for further details please see "Publication of final regulations on patent linkage and term restoration relating to CETA"). The guidance, which became effective on 11 May 2018, reflects existing administrative practices – for example, replacing references to 'patent hold' with Health Canada's preferred term, 'intellectual property hold'.
Further revisions include the introduction of:
For further information on this topic please contact Abigail Smith at Smart & Biggar/Fetherstonhaugh by telephone (+1 416 593 5514) or email (firstname.lastname@example.org). The Smart & Biggar website can be accessed at www.smart-biggar.ca.
The materials contained on this website are for general information purposes only and are subject to the disclaimer.
ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.